CSI Market
Sign In | Register

Asensus Surgical Inc (ASXC) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ASXC quarterly Cash Flow →
A period-by-period view of cash flow from Asensus Surgical Inc to Dec 31 2019 helps clarify how Dec 31 2023's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
12 Months 		(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Operating Activities
Income-78.43
Depreciation & amortization3.28
Amortization of Other Assets0.45
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability1.34
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.13
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation7.92
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-1.23
Write Off Of Deferred Debt Issuance Cost-
Stock Based Compensation Expense Related To Share Exchange-
Accretion Of Bond Discount-
Restructuring Reserve Settled Without Cash-
Transfer Of Inventory To Property And Equipment2.69
Non Employee Warrant Awards-
Change In Fair Value Of Contingent Consideration-
Gain Loss On Sale Of Developed System Assets Net-
Reversal Of Transfer Fee Accrual-
Goodwill And Intangible Asset Impairment-
Increase Decrease In Contract With Customer Liability-0.06
Business Combination Interest Expense On Deferred Consideration-
Increase Decrease In Operating Lease Right Of Use Assets0.23
Increase Decrease In Operating Lease Liability0.76
Income taxes0.13
Losses/ -gains on Investments net0.00
Accounts Receivable2.06
Increase (Decrease) in Accounts Payable0.57
Increase (Decrease) in Interest Payable, Net0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense-0.42
Other Working Capital-1.17
Other Noncash Income (Expense)0.00
Other net0.48
Payments for (Proceeds from) Other Operating Activities1.53
Discontinued operations0.00
Net Cash flow from Operating Activities-63.63
Investing Activities
Capital Expenditures-0.56
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities77.34
Payments to Acquire Available-for-sale Securities, Debt-12.27
Real Estate Investments0.00
Payment Received From Insiders Profit-
Payments To Acquire Intellectual Property-
Proceeds From Sale Of Developed System Assets Net-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities64.51
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-0.50
Other net10.12
Net Cash Provided In Connection With Acquisition-
Proceeds From Stockholder Loans-
Repayment Of Stockholder Loans-
Payment Of Contingent Consideration-
Proceeds From Issuance Of Debt And Warrants-
Proceeds From Issuance Of Common Stock And Warrants-
Proceeds From Issuance Of Common Stock For Sale Of Property-
Proceeds From Stock Options And Warrants Exercised0.02
Proceeds From Issuance Of Equity Net-
Proceeds From Issuance Of Common Stock Net-
Proceeds From Issuance Of Debt And Warrants Net Of Issuance Costs-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents19.28
Operating Lease Payments0.98
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities9.63
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-64.19
Total Cash Flow11.27
4 historic quarters locked

Sign in to unlock the full Asensus Surgical Inc cash flow history.

Sign In Create Free Account

About Asensus Surgical Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-24-008871

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License